Accreditation Expired
IgAN: Pathogenesis and pathophysiology
GlobalAn overview of the latest understanding of the pathogenesis and pathophysiology of IgAN
IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and the most common glomerular disease worldwide. But its pathogenesis has not yet been fully elucidated, leaving some questions so far unanswered. In this video, Dr Richard Lafayette presents an overview of our current understanding of how this disease develops and presents.
By completing this module you can qualify for 0.25 CME credits. To claim your credits, you must watch the video and successfully pass the post-module assessment.
Nephrologists
After taking part in this activity, learners will be able to:
Type of affiliation / financial interest | Name of commercial company |
---|---|
Research | Travere, Omeros, Calliditas, Vera, Otsuka/Visterra |
Consulting | Travere, Omeros, Calliditas, Vera, Otsuka/Visterra |
Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
This independent educational activity is supported by an educational grant from Travere Therapeutics. The educational content has been developed by Liberum IME and validated by an independent steering committee; Travere Therapeutics has had no influence on the content of this education.
This module was accredited on the 1st March 2022 and will expire on the 1st March 2023.
The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change.
An overview of the latest understanding of the pathogenesis and pathophysiology of IgAN